MENU
CAPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Capricor Therapeutics (CAPR) Earnings Date & Reports
Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
CAPR is expected to report earnings to fall 83.17% to -11 cents per share on November 17
Q3'26
Est.
$-0.12
Q2'26
Missed
by $0.10
Q1'26
Missed
by $0.07
Q4'25
Missed
by $0.11
Q3'25
Est.
$-0.54
The last earnings report on August 13 showed earnings per share of -69 cents, missing the estimate of -60 cents. With 887.26K shares outstanding, the current market capitalization sits at 506.39M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Develops innovative products for the treatment of cardiovascular diseases
Industry Biotechnology
Industry
Biotechnology
Address
10865 Road to the Cure
Phone
+1 858 727-1755
Employees
160
Web
https://www.capricor.com